1. Home
  2. GSBC vs IVA Comparison

GSBC vs IVA Comparison

Compare GSBC & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSBC
  • IVA
  • Stock Information
  • Founded
  • GSBC 1923
  • IVA 2011
  • Country
  • GSBC United States
  • IVA France
  • Employees
  • GSBC N/A
  • IVA N/A
  • Industry
  • GSBC Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSBC Finance
  • IVA Health Care
  • Exchange
  • GSBC Nasdaq
  • IVA Nasdaq
  • Market Cap
  • GSBC 676.3M
  • IVA 769.0M
  • IPO Year
  • GSBC N/A
  • IVA 2020
  • Fundamental
  • Price
  • GSBC $60.52
  • IVA $4.59
  • Analyst Decision
  • GSBC Hold
  • IVA Strong Buy
  • Analyst Count
  • GSBC 2
  • IVA 7
  • Target Price
  • GSBC $60.50
  • IVA $16.57
  • AVG Volume (30 Days)
  • GSBC 36.6K
  • IVA 98.4K
  • Earning Date
  • GSBC 10-15-2025
  • IVA 09-29-2025
  • Dividend Yield
  • GSBC 2.64%
  • IVA N/A
  • EPS Growth
  • GSBC 17.24
  • IVA N/A
  • EPS
  • GSBC 5.86
  • IVA N/A
  • Revenue
  • GSBC $224,299,000.00
  • IVA $19,929,536.00
  • Revenue This Year
  • GSBC N/A
  • IVA N/A
  • Revenue Next Year
  • GSBC N/A
  • IVA N/A
  • P/E Ratio
  • GSBC $10.34
  • IVA N/A
  • Revenue Growth
  • GSBC 4.82
  • IVA N/A
  • 52 Week Low
  • GSBC $47.58
  • IVA $2.11
  • 52 Week High
  • GSBC $68.02
  • IVA $6.55
  • Technical
  • Relative Strength Index (RSI)
  • GSBC 44.40
  • IVA 36.93
  • Support Level
  • GSBC $59.56
  • IVA $5.59
  • Resistance Level
  • GSBC $61.14
  • IVA $6.55
  • Average True Range (ATR)
  • GSBC 0.97
  • IVA 0.33
  • MACD
  • GSBC -0.24
  • IVA -0.21
  • Stochastic Oscillator
  • GSBC 27.31
  • IVA 7.99

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: